OSPREY MEDICAL INC - Announcements

0.00%

20.0¢

Currently unlisted.

Osprey Medical, Inc. is a commercial stage company, which is focused on protecting... Osprey Medical, Inc. is a commercial stage company, which is focused on protecting patients from the harmful effects of X-ray dye (contrast) used during commonly performed angiographic imaging procedures. The Company’s products include AVERT, AVERT Plus, the DyeVert NG, DyeVert Plus, and DyeVert Plus EZ Systems. The AVERT Plus System reduces and monitors the amount of contrast dye used in commonly performed heart and peripheral vascular procedures. The DyeVert System is a self-adjusting product that reduces the amount of contrast dye used in commonly performed heart and peripheral procedures. DyeVert interfaces with syringe-manifold systems. These technologies are available with the United States Food and Drug Administration cleared indication for dye volume reduction. Its dye reduction and monitoring technologies are designed to help physicians minimize dye usage and reduce kidney damage associated with the use of contrast media for common cardiovascular procedures.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

OSP	Quarterly Results and Investor Conference Call Notification		08/04/19	236.86KB	Share
OSP	Change in Substantial Holding		03/04/19	257.94KB	Share
OSP	Appendix 4G		26/03/19	183.23KB	Share
OSP	2018 Corporate Governance Statement		26/03/19	322.18KB	Share
OSP	2018 Annual Report		26/03/19	1.89MB	Share
OSP	DyeVert Clinical Data Featured at US Scientific Conferences		20/03/19	289.49KB	Share
OSP	Appendix 3B		08/03/19	443.24KB	Share
OSP	Appendix 3Y		08/03/19	139.21KB	Share
OSP	Osprey Appoints Mr Jim Surek as Vice President, Sales		04/03/19	241.31KB	Share
OSP	Investor Presentation	PRICE SENSITIVE	04/03/19	5.96MB	Share
OSP	Preliminary Final Report and Consolidated Financial Accounts	PRICE SENSITIVE	26/02/19	879.5KB	Share
OSP	2019 Annual Meeting of Stockholders		01/02/19	292.13KB	Share
OSP	Appendix 4C	PRICE SENSITIVE	29/01/19	438.39KB	Share
OSP	Quarterly Results and Investor Conference Call Notification		17/01/19	307.02KB	Share
OSP	Appendix 3B		15/01/19	455.08KB	Share
OSP	Appendix 3B		21/12/18	455.22KB	Share
OSP	Change in substantial holding		14/12/18	187.98KB	Share
OSP	Disclosure of Interests for Allan Gray Australia		10/12/18	258.35KB	Share
OSP	Change in substantial holding		07/12/18	453.27KB	Share
OSP	Appendix 3Y		03/12/18	139.24KB	Share
OSP	Osprey awarded a group purchasing agreement with Premier	PRICE SENSITIVE	03/12/18	272.28KB	Share
OSP	Appendix 3B		30/11/18	206.58KB	Share
OSP	Allotment of Securities under Entitlement Offer		30/11/18	129.93KB	Share
OSP	Completion of Entitlement Offer	PRICE SENSITIVE	28/11/18	291.17KB	Share
OSP	Entitlement Offer - Update on shortfall	PRICE SENSITIVE	19/11/18	289.41KB	Share
OSP	Change in substantial holding		13/11/18	131.34KB	Share
OSP	Change in substantial holding		13/11/18	101.87KB	Share
OSP	Extension of Closing Date of Entitlement Offer	PRICE SENSITIVE	13/11/18	301.2KB	Share
OSP	Change in substantial holding		13/11/18	106.87KB	Share
OSP	Change in substantial holding		13/11/18	381.94KB	Share
OSP	Change in substantial holding		13/11/18	379.07KB	Share
OSP	Change in substantial holding		13/11/18	160.3KB	Share
OSP	Notice of despatch of entitlement offer documents		07/11/18	851.86KB	Share
OSP	Cleansing Notice		06/11/18	347.33KB	Share
OSP	Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b)		06/11/18	324.85KB	Share
OSP	Appendix 3B		06/11/18	403.32KB	Share
OSP	Completion of Private Placement	PRICE SENSITIVE	06/11/18	293.31KB	Share
OSP	Entitlement Offer Notification to Ineligible CDI holders		31/10/18	432.91KB	Share
OSP	Entitlement Offer Notice to Holders of CDIs		31/10/18	373.09KB	Share
OSP	Notice to Optionholders		30/10/18	105.37KB	Share
OSP	Cleansing Notice		30/10/18	148.3KB	Share
OSP	Appendix 3B		30/10/18	182.01KB	Share
OSP	Entitlement Offer Booklet	PRICE SENSITIVE	30/10/18	301.01KB	Share
OSP	Investor Presentation	PRICE SENSITIVE	30/10/18	2.59MB	Share
OSP	Appendix 4C	PRICE SENSITIVE	30/10/18	765.39KB	Share
OSP	Capital raising to accelerate GPO focused growth strategy	PRICE SENSITIVE	30/10/18	376.73KB	Share
OSP	Trading Halt	PRICE SENSITIVE	29/10/18	470.26KB	Share
OSP	Quarterly Results and Investor Conference Call Notification		25/10/18	312.73KB	Share
OSP	Acute Kidney Injury in spotlight at international conference		26/09/18	309.16KB	Share
OSP	Ceasing to be a substantial holder		25/09/18	340.27KB	Share
OSP	Osprey and GE Healthcare Launch New Educational Program	PRICE SENSITIVE	20/09/18	392.23KB	Share
OSP	Appendix 3B		12/09/18	360.27KB	Share
OSP	Osprey Medical begins market access process in UK	PRICE SENSITIVE	07/09/18	241.17KB	Share
OSP	Half Yearly Accounts Report	PRICE SENSITIVE	27/08/18	333.46KB	Share
OSP	Appendix 4D Half Year Report & Accounts	PRICE SENSITIVE	27/08/18	549.59KB	Share
OSP	CEO Investor Presentation July August 2018		30/07/18	11.5MB	Share
OSP	CEO Investor Presentation at Bioshares Biotech Summit 2018		26/07/18	11.84MB	Share
OSP	Osprey Investor Newsletter		19/07/18	1.8MB	Share
OSP	Appendix 4C	PRICE SENSITIVE	19/07/18	1.06MB	Share
OSP	Quarterly Results and Investor Conference Call Notification		12/07/18	88.13KB	Share
OSP	Change in substantial holding		20/06/18	188.52KB	Share
OSP	Appendix 3Y		08/06/18	132.74KB	Share
OSP	Appendix 3B		01/06/18	187.43KB	Share
OSP	Appendix 3Y		15/05/18	131.5KB	Share
OSP	Appendix 3Y		15/05/18	142.28KB	Share
OSP	Appendix 3Y		15/05/18	176.82KB	Share
OSP	Appendix 3Y		15/05/18	163.83KB	Share
OSP	2018 Annual Meeting Results		10/05/18	127.26KB	Share
OSP	Chairman's Address and CEO's Presentation at Annual Meeting	PRICE SENSITIVE	10/05/18	10.14MB	Share
OSP	Investor Presentation		07/05/18	11.49MB	Share
OSP	Strong recovery for DyeVert Plus in April 2018	PRICE SENSITIVE	02/05/18	95.67KB	Share
OSP	DyeVert Plus Featured at SCAI 2018 Scientific Sessions		30/04/18	1.64MB	Share
OSP	Appendix 4C	PRICE SENSITIVE	26/04/18	1.77MB	Share
OSP	Notice of Appendix 4C Release and Investor Conference Call		20/04/18	88.27KB	Share
OSP	Notice of Annual Meeting of Stockholders and Proxy Statement		09/04/18	1.04MB	Share
OSP	Appendix 4G		26/03/18	287.65KB	Share
OSP	2017 Corporate Governance Statement		26/03/18	243.88KB	Share
OSP	2017 Annual Report		26/03/18	1.91MB	Share
OSP	Osprey Medical National Kidney Month Programs		21/03/18	1.06MB	Share
OSP	Appendix 3B		28/02/18	185.54KB	Share
OSP	Preliminary Final Report and Consolidated Financial Accounts	PRICE SENSITIVE	26/02/18	470.03KB	Share
OSP	2018 Annual Meeting of Stockholders		06/02/18	89.18KB	Share
OSP	Appendix 4C	PRICE SENSITIVE	24/01/18	1.93MB	Share
OSP	Appendix 3B		08/01/18	189.61KB	Share
OSP	Appendix 3B		20/12/17	191.11KB	Share
OSP	Investor Presentation		04/12/17	8.11MB	Share
OSP	OSP highlighted at international cardiovascular conference		03/11/17	135.3KB	Share
OSP	Becoming a substantial holder		26/10/17	767.3KB	Share
OSP	Appendix 3B		18/10/17	186.24KB	Share
OSP	Appendix 4C	PRICE SENSITIVE	16/10/17	1.41MB	Share
OSP	Appendix 3Y		12/10/17	128.44KB	Share
OSP	Appendix 3B		12/10/17	186.04KB	Share
OSP	Substantial Holder Notice		06/09/17	569.07KB	Share
OSP	Appendix 3Y		04/09/17	131.34KB	Share
OSP	Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b)		04/09/17	123.39KB	Share
OSP	Cleansing Statement		04/09/17	115.89KB	Share
OSP	Appendix 3B		04/09/17	195.33KB	Share
OSP	Security Issue Completes Placement and Entitlement Offer		04/09/17	97.26KB	Share
OSP	Successful completion of A$10.3 million entitlement offer	PRICE SENSITIVE	30/08/17	114.27KB	Share
OSP	Entitlement Offer Closing Date		22/08/17	102.48KB	Share

OSP Quarterly Results and Investor Conference Call Notification
08/04/19		236.86KB	Share
OSP Change in Substantial Holding
03/04/19		257.94KB	Share
OSP Appendix 4G
26/03/19		183.23KB	Share
OSP 2018 Corporate Governance Statement
26/03/19		322.18KB	Share
OSP 2018 Annual Report
26/03/19		1.89MB	Share
OSP DyeVert Clinical Data Featured at US Scientific Conferences
20/03/19		289.49KB	Share
OSP Appendix 3B
08/03/19		443.24KB	Share
OSP Appendix 3Y
08/03/19		139.21KB	Share
OSP Osprey Appoints Mr Jim Surek as Vice President, Sales
04/03/19		241.31KB	Share
OSP Investor Presentation
04/03/19	PRICE SENSITIVE	5.96MB	Share
OSP Preliminary Final Report and Consolidated Financial Accounts
26/02/19	PRICE SENSITIVE	879.5KB	Share
OSP 2019 Annual Meeting of Stockholders
01/02/19		292.13KB	Share
OSP Appendix 4C
29/01/19	PRICE SENSITIVE	438.39KB	Share
OSP Quarterly Results and Investor Conference Call Notification
17/01/19		307.02KB	Share
OSP Appendix 3B
15/01/19		455.08KB	Share
OSP Appendix 3B
21/12/18		455.22KB	Share
OSP Change in substantial holding
14/12/18		187.98KB	Share
OSP Disclosure of Interests for Allan Gray Australia
10/12/18		258.35KB	Share
OSP Change in substantial holding
07/12/18		453.27KB	Share
OSP Appendix 3Y
03/12/18		139.24KB	Share
OSP Osprey awarded a group purchasing agreement with Premier
03/12/18	PRICE SENSITIVE	272.28KB	Share
OSP Appendix 3B
30/11/18		206.58KB	Share
OSP Allotment of Securities under Entitlement Offer
30/11/18		129.93KB	Share
OSP Completion of Entitlement Offer
28/11/18	PRICE SENSITIVE	291.17KB	Share
OSP Entitlement Offer - Update on shortfall
19/11/18	PRICE SENSITIVE	289.41KB	Share
OSP Change in substantial holding
13/11/18		131.34KB	Share
OSP Change in substantial holding
13/11/18		101.87KB	Share
OSP Extension of Closing Date of Entitlement Offer
13/11/18	PRICE SENSITIVE	301.2KB	Share
OSP Change in substantial holding
13/11/18		106.87KB	Share
OSP Change in substantial holding
13/11/18		381.94KB	Share
OSP Change in substantial holding
13/11/18		379.07KB	Share
OSP Change in substantial holding
13/11/18		160.3KB	Share
OSP Notice of despatch of entitlement offer documents
07/11/18		851.86KB	Share
OSP Cleansing Notice
06/11/18		347.33KB	Share
OSP Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b)
06/11/18		324.85KB	Share
OSP Appendix 3B
06/11/18		403.32KB	Share
OSP Completion of Private Placement
06/11/18	PRICE SENSITIVE	293.31KB	Share
OSP Entitlement Offer Notification to Ineligible CDI holders
31/10/18		432.91KB	Share
OSP Entitlement Offer Notice to Holders of CDIs
31/10/18		373.09KB	Share
OSP Notice to Optionholders
30/10/18		105.37KB	Share
OSP Cleansing Notice
30/10/18		148.3KB	Share
OSP Appendix 3B
30/10/18		182.01KB	Share
OSP Entitlement Offer Booklet
30/10/18	PRICE SENSITIVE	301.01KB	Share
OSP Investor Presentation
30/10/18	PRICE SENSITIVE	2.59MB	Share
OSP Appendix 4C
30/10/18	PRICE SENSITIVE	765.39KB	Share
OSP Capital raising to accelerate GPO focused growth strategy
30/10/18	PRICE SENSITIVE	376.73KB	Share
OSP Trading Halt
29/10/18	PRICE SENSITIVE	470.26KB	Share
OSP Quarterly Results and Investor Conference Call Notification
25/10/18		312.73KB	Share
OSP Acute Kidney Injury in spotlight at international conference
26/09/18		309.16KB	Share
OSP Ceasing to be a substantial holder
25/09/18		340.27KB	Share
OSP Osprey and GE Healthcare Launch New Educational Program
20/09/18	PRICE SENSITIVE	392.23KB	Share
OSP Appendix 3B
12/09/18		360.27KB	Share
OSP Osprey Medical begins market access process in UK
07/09/18	PRICE SENSITIVE	241.17KB	Share
OSP Half Yearly Accounts Report
27/08/18	PRICE SENSITIVE	333.46KB	Share
OSP Appendix 4D Half Year Report & Accounts
27/08/18	PRICE SENSITIVE	549.59KB	Share
OSP CEO Investor Presentation July August 2018
30/07/18		11.5MB	Share
OSP CEO Investor Presentation at Bioshares Biotech Summit 2018
26/07/18		11.84MB	Share
OSP Osprey Investor Newsletter
19/07/18		1.8MB	Share
OSP Appendix 4C
19/07/18	PRICE SENSITIVE	1.06MB	Share
OSP Quarterly Results and Investor Conference Call Notification
12/07/18		88.13KB	Share
OSP Change in substantial holding
20/06/18		188.52KB	Share
OSP Appendix 3Y
08/06/18		132.74KB	Share
OSP Appendix 3B
01/06/18		187.43KB	Share
OSP Appendix 3Y
15/05/18		131.5KB	Share
OSP Appendix 3Y
15/05/18		142.28KB	Share
OSP Appendix 3Y
15/05/18		176.82KB	Share
OSP Appendix 3Y
15/05/18		163.83KB	Share
OSP 2018 Annual Meeting Results
10/05/18		127.26KB	Share
OSP Chairman's Address and CEO's Presentation at Annual Meeting
10/05/18	PRICE SENSITIVE	10.14MB	Share
OSP Investor Presentation
07/05/18		11.49MB	Share
OSP Strong recovery for DyeVert Plus in April 2018
02/05/18	PRICE SENSITIVE	95.67KB	Share
OSP DyeVert Plus Featured at SCAI 2018 Scientific Sessions
30/04/18		1.64MB	Share
OSP Appendix 4C
26/04/18	PRICE SENSITIVE	1.77MB	Share
OSP Notice of Appendix 4C Release and Investor Conference Call
20/04/18		88.27KB	Share
OSP Notice of Annual Meeting of Stockholders and Proxy Statement
09/04/18		1.04MB	Share
OSP Appendix 4G
26/03/18		287.65KB	Share
OSP 2017 Corporate Governance Statement
26/03/18		243.88KB	Share
OSP 2017 Annual Report
26/03/18		1.91MB	Share
OSP Osprey Medical National Kidney Month Programs
21/03/18		1.06MB	Share
OSP Appendix 3B
28/02/18		185.54KB	Share
OSP Preliminary Final Report and Consolidated Financial Accounts
26/02/18	PRICE SENSITIVE	470.03KB	Share
OSP 2018 Annual Meeting of Stockholders
06/02/18		89.18KB	Share
OSP Appendix 4C
24/01/18	PRICE SENSITIVE	1.93MB	Share
OSP Appendix 3B
08/01/18		189.61KB	Share
OSP Appendix 3B
20/12/17		191.11KB	Share
OSP Investor Presentation
04/12/17		8.11MB	Share
OSP OSP highlighted at international cardiovascular conference
03/11/17		135.3KB	Share
OSP Becoming a substantial holder
26/10/17		767.3KB	Share
OSP Appendix 3B
18/10/17		186.24KB	Share
OSP Appendix 4C
16/10/17	PRICE SENSITIVE	1.41MB	Share
OSP Appendix 3Y
12/10/17		128.44KB	Share
OSP Appendix 3B
12/10/17		186.04KB	Share
OSP Substantial Holder Notice
06/09/17		569.07KB	Share
OSP Appendix 3Y
04/09/17		131.34KB	Share
OSP Disclosure Under Listing Rules 3.10.5A and 7.1A.4(b)
04/09/17		123.39KB	Share
OSP Cleansing Statement
04/09/17		115.89KB	Share
OSP Appendix 3B
04/09/17		195.33KB	Share
OSP Security Issue Completes Placement and Entitlement Offer
04/09/17		97.26KB	Share
OSP Successful completion of A$10.3 million entitlement offer
30/08/17	PRICE SENSITIVE	114.27KB	Share
OSP Entitlement Offer Closing Date
22/08/17		102.48KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

OSPREY MEDICAL INC - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available